Becker's Healthcare November 28, 2022
Bionaut Labs, a company that makes micro-robotics used in the treatment of central nervous system diseases, has raised $43 million in series B financing.
Bionaut’s robots work to deliver drugs at deep levels in the midbrain. The company will use this financing to advance its clinical trials of treatment programs for malignant glioma brain tumors and Dandy-Walker Syndrome, according to a Nov. 28 Bionaut news release.
Khosla Ventures...
Today's Sponsors
Today's Sponsor